Private Advisor Group, LLC Astrazeneca PLC Transaction History

Private Advisor Group, LLC

$15.6 Billion
Q3 2024

A detailed history of Private Advisor Group, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Private Advisor Group, LLC holds 64,523 shares of AZN stock, worth $4.61 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

64,523

Previous 65,105 0.89%

Holding current value

$4.61 Million

Previous $5.08 Million 0.98%

% of portfolio

0.03%

Previous 0.03%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 22, 2024	SELL	$76.67 - $87.62 $44,621 - $50,994	-582 Reduced 0.89%	64,523 $5.03 Million
Q2 2024 Aug 05, 2024	BUY	$66.81 - $80.83 $304,319 - $368,180	4,555 Added 7.52%	65,105 $5.08 Million
Q1 2024 Apr 30, 2024	SELL	$61.03 - $69.57 $31,979 - $36,454	-524 Reduced 0.86%	60,550 $4.1 Million
Q4 2023 Feb 06, 2024	SELL	$61.89 - $69.28 $240,566 - $269,291	-3,887 Reduced 5.98%	61,074 $4.11 Million
Q3 2023 Nov 02, 2023	SELL	$64.85 - $71.7 $295,845 - $327,095	-4,562 Reduced 6.56%	64,961 $4.4 Million
Q2 2023 Aug 09, 2023	SELL	$69.91 - $75.81 $163,519 - $177,319	-2,339 Reduced 3.25%	69,523 $4.98 Million
Q1 2023 May 10, 2023	BUY	$63.15 - $71.6 $104,829 - $118,855	1,660 Added 2.36%	71,862 $4.99 Million
Q4 2022 Jan 18, 2023	BUY	$54.21 - $70.44 $84,404 - $109,675	1,557 Added 2.27%	70,202 $0
Q3 2022 Oct 14, 2022	SELL	$53.02 - $135.75 $1.77 Million - $4.52 Million	-33,329 Reduced 32.68%	68,645 $3.76 Million
Q2 2022 Jul 13, 2022	BUY	$59.26 - $71.14 $163,024 - $195,706	2,751 Added 2.77%	101,974 $6.74 Million
Q1 2022 May 12, 2022	BUY	$55.72 - $67.12 $147,212 - $177,331	2,642 Added 2.74%	99,223 $6.58 Million
Q4 2021 Feb 10, 2022	SELL	$54.02 - $63.83 $3.98 Million - $4.7 Million	-73,670 Reduced 43.27%	96,581 $5.63 Million
Q3 2021 Oct 14, 2021	BUY	$55.56 - $60.79 $4.86 Million - $5.31 Million	87,418 Added 105.54%	170,251 $10.2 Million
Q2 2021 Aug 12, 2021	BUY	$48.42 - $60.18 $4,067 - $5,055	84 Added 0.1%	82,833 $4.96 Million
Q1 2021 Apr 22, 2021	BUY	$47.16 - $54.44 $2 Million - $2.31 Million	42,435 Added 105.26%	82,749 $4.11 Million
Q4 2020 Apr 01, 2021	BUY	$48.52 - $58.02 $410,818 - $491,255	8,467 Added 26.59%	40,314 $2.02 Million
Q3 2020 Nov 02, 2020	BUY	$53.07 - $61.1 $159,740 - $183,911	3,010 Added 10.44%	31,847 $1.72 Million
Q2 2020 Aug 17, 2020	BUY	$43.1 - $55.31 $75,683 - $97,124	1,756 Added 6.48%	28,837 $1.53 Million
Q1 2020 May 12, 2020	BUY	$37.79 - $51.33 $63,978 - $86,901	1,693 Added 6.67%	27,081 $1.21 Million
Q4 2019 Feb 10, 2020	SELL	$42.46 - $50.46 $950,467 - $1.13 Million	-22,385 Reduced 46.86%	25,388 $1.27 Million
Q3 2019 Nov 13, 2019	BUY	$40.12 - $45.47 $181,422 - $205,615	4,522 Added 10.46%	47,773 $2.23 Million
Q2 2019 Aug 14, 2019	BUY	$37.28 - $41.68 $596,629 - $667,046	16,004 Added 58.74%	43,251 $1.74 Million
Q1 2019 May 13, 2019	BUY	$35.49 - $43.02 $224,332 - $271,929	6,321 Added 30.21%	27,247 $1.1 Million
Q4 2018 Feb 11, 2019	SELL	$36.86 - $41.49 $447,148 - $503,315	-12,131 Reduced 36.7%	20,926 $795,000
Q3 2018 Nov 01, 2018	SELL	$34.76 - $39.72 $1.09 Million - $1.25 Million	-31,422 Reduced 48.73%	33,057 $1.31 Million
Q2 2018 Aug 09, 2018	BUY	$34.55 - $37.05 $1.61 Million - $1.72 Million	46,464 Added 257.92%	64,479 $2.26 Million
Q1 2018 May 09, 2018	SELL	$32.97 - $36.63 $1.12 Million - $1.25 Million	-34,056 Reduced 65.4%	18,015 $630,000
Q4 2017 Feb 07, 2018	BUY	$32.09 - $34.78 $410,013 - $444,384	12,777 Added 32.52%	52,071 $1.84 Million
Q3 2017 Nov 13, 2017	BUY	$28.96 - $34.0 $198,897 - $233,512	6,868 Added 21.18%	39,294 $1.35 Million
Q2 2017 Aug 10, 2017	BUY	N/A	32,426	32,426 $1.09 Million

Others Institutions Holding AZN

# of Institutions

1,345

Shares Held

492M

Call Options Held

4.99M

Put Options Held

3.18M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $221B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Advisor Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Advisor Group, LLC with notifications on news.

Account

Private Advisor Group, LLC Astrazeneca PLC Transaction History